ATE312914T1 - Rdgb-proteine - Google Patents

Rdgb-proteine

Info

Publication number: ATE312914T1
Authority: AT; Austria
Prior art keywords: rdgb; features; proteins; diseases; signal transduction
Prior art date: 1996-10-11

Application number

AT97945311T

Other languages

English (en)

Inventor

Sima Lev

Gregory D Plowman

Joseph Schlessinger

Original Assignee

Sugen Inc

Univ New York

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-11

Filing date

1997-09-26

Publication date

2005-12-15

1997-09-26 Application filed by Sugen Inc, Univ New York filed Critical Sugen Inc

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE312914T1 publication Critical patent/ATE312914T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
- C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Insects & Arthropods (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Soft Magnetic Materials (AREA)
Power Conversion In General (AREA)
Amplifiers (AREA)
Bipolar Transistors (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT97945311T 1996-10-11 1997-09-26 Rdgb-proteine ATE312914T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2733796P	1996-10-11	1996-10-11
PCT/US1997/017374 WO1998016639A1 (en)	1996-10-11	1997-09-26	Rdgb-proteins

Publications (1)

Publication Number	Publication Date
ATE312914T1 true ATE312914T1 (de)	2005-12-15

Family

ID=21837130

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97945311T ATE312914T1 (de)	1996-10-11	1997-09-26	Rdgb-proteine

Country Status (8)

Country	Link
US (2)	US6117673A (de)
EP (1)	EP0931146B1 (de)
AT (1)	ATE312914T1 (de)
AU (1)	AU4654097A (de)
CA (1)	CA2268034A1 (de)
DE (1)	DE69734890T2 (de)
ES (1)	ES2262195T3 (de)
WO (1)	WO1998016639A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1344400A (en) *	1998-11-18	2000-06-05	Incyte Pharmaceuticals, Inc.	Inflammation-associated genes
US6861442B1 (en)	1998-12-30	2005-03-01	Sugen, Inc.	PYK2 and inflammation
EP1630559A3 (de) *	1998-12-30	2006-06-07	Sugen, Inc.	PYK2 (RAFTK) und Entzündung
WO2000040971A1 (en) *	1998-12-31	2000-07-13	Sugen, Inc.	Pyk2 (raftk) and inflammation
WO2000049144A2 (en) *	1999-02-22	2000-08-24	Sugen, Inc.	Pyk2 binding proteins
CN1324836A (zh) *	2000-05-19	2001-12-05	上海博德基因开发有限公司	一种新的多肽——视网膜结合位点12和编码这种多肽的多核苷酸

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5837815A (en) *	1994-12-15	1998-11-17	Sugen, Inc.	PYK2 related polypeptide products

1997
- 1997-09-26 ES ES97945311T patent/ES2262195T3/es not_active Expired - Lifetime
- 1997-09-26 EP EP97945311A patent/EP0931146B1/de not_active Expired - Lifetime
- 1997-09-26 US US08/938,291 patent/US6117673A/en not_active Expired - Fee Related
- 1997-09-26 AU AU46540/97A patent/AU4654097A/en not_active Abandoned
- 1997-09-26 CA CA002268034A patent/CA2268034A1/en not_active Abandoned
- 1997-09-26 AT AT97945311T patent/ATE312914T1/de not_active IP Right Cessation
- 1997-09-26 DE DE69734890T patent/DE69734890T2/de not_active Expired - Fee Related
- 1997-09-26 WO PCT/US1997/017374 patent/WO1998016639A1/en active IP Right Grant
2000
- 2000-06-07 US US09/589,619 patent/US6576442B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0931146B1 (de)	2005-12-14
WO1998016639A1 (en)	1998-04-23
DE69734890T2 (de)	2006-08-24
CA2268034A1 (en)	1998-04-23
US6576442B1 (en)	2003-06-10
AU4654097A (en)	1998-05-11
US6117673A (en)	2000-09-12
EP0931146A1 (de)	1999-07-28
ES2262195T3 (es)	2006-11-16
DE69734890D1 (de)	2006-01-19

Similar Documents

Publication	Publication Date	Title
EP1361229A3 (de)	2004-02-18	Verwendung von Tyrosine Kinase (PYK2) zur Produktion von Antikörper
PT948604E (pt)	2004-10-29	Produtos e metodos relacionados com pyk2
PT868519E (pt)	2006-05-31	Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2
ATE408422T1 (de)	2008-10-15	Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
ATE182180T1 (de)	1999-07-15	Lamanin-ketten: diagnostische und therapeutische verwendung
CY1105446T1 (el)	2010-04-28	Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
DE69117949D1 (de)	1996-04-18	Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
SE8902532D0 (sv)	1989-07-14	Bestaemning av plasmaproteiner
ATE240743T1 (de)	2003-06-15	Verfahren und substanzen gegen protozoen
ATE168135T1 (de)	1998-07-15	Diagnose von retinoblastoma
WO2000034511A3 (de)	2000-11-16	Peptid screening test zum nachweis von ass
ATE395433T1 (de)	2008-05-15	Screeningverfahren für geeignete wirkstoffe
ATE251886T1 (de)	2003-11-15	Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
DE69734890D1 (de)	2006-01-19	Rdgb-proteine
NO963487L (no)	1996-08-28	Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
ATE517629T1 (de)	2011-08-15	Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
DK0764273T3 (da)	1999-06-23	Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DK0870036T3 (da)	2008-11-24	Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
MXPA02000293A (es)	2004-05-21	Isoformas de la amp ciclico fosfodiesterasa y metodos de uso.
ATE321135T1 (de)	2006-04-15	Verfahren zur diagnose und behandlung neurologischer erkrankungen
DE3882411D1 (de)	1993-08-26	Verfahren zur trennung von aktiviertem menschlichem protein c.
WO2003044170A3 (en)	2005-04-28	Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
DE69521281D1 (de)	2001-07-19	Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
WO1998045408A3 (en)	1999-01-07	Novel ectoparasite saliva proteins and apparatus to collect such proteins

Legal Events

Date	Code	Title	Description
2006-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties